Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, According to Tufts Center for the Study of Drug Development
May 09, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 9, 2012) - Drug sponsors experienced a mixed regulatory burden under the FDA Amendments Act, which was also the fourth iteration of the Prescription Drug User Fee Act...
Drug Companies Are Looking to Shorten Time to Early Clinical Development, According to Tufts Center for the Study of Drug Development
April 26, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Apr 26, 2012) - Drug companies looking to increase the efficiency and productivity of their R&D pipelines are turning to a host of techniques and approaches aimed at...
Drugs to Treat CNS Diseases Take 35% Longer to Develop Than Other Drugs, According to Tufts Center for the Study of Drug Development
March 06, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Mar 6, 2012) - Drugs developed to treat central nervous system (CNS) diseases take 35% longer to complete clinical trials and receive regulatory approval compared to other...
Ricoh Innovations Expands R&D Into India
February 14, 2012 22:00 ET
|
Ricoh Innovations, Inc.
MENLO PARK, CA--(Marketwire - Feb 14, 2012) - Ricoh Innovations, Inc. ("RII"), a Silicon Valley-based subsidiary of Ricoh Company, Ltd., which develops innovative technologies and new business...
Drug Company Executives Are Expanding Their Use of Strategic Partnerships, According to Tufts Center for the Study of Drug Development
January 26, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 26, 2012) - Pharmaceutical and biopharmaceutical companies, under pressure to increase R&D productivity, are expanding their use of strategic partnerships to bring...
Today's Key Leadership Challenge: Making Innovation Everyone's Mandate
January 11, 2012 11:15 ET
|
Innosight
BOSTON, MA--(Marketwire - Jan 11, 2012) - Innovation mastery remains elusive, despite decades of superb thinking and work on the topic. Too often, companies mistake creativity for innovation,...
Drug Companies Are Taking Steps to Improve R&D Productivity, According to Tufts Center for the Study of Drug Development
January 05, 2012 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Jan 5, 2012) - Although drug companies are pursuing innovative approaches to increase the pace and reduce the cost of drug development, the greatest advances will come...
Battelle-R&D Magazine Annual Global Funding Forecast Predicts R&D Spending Growth Will Continue While Globalization Accelerates
December 16, 2011 12:13 ET
|
Battelle
COLUMBUS, OH--(Marketwire - Dec 16, 2011) - The Battelle-R&D Magazine annual Global R&D Funding Forecast released today shows global research and development (R&D) spending is expected...
Number of Monoclonal Antibody Products in Development Continues to Increase, According to Tufts Center for the Study of Drug Development
November 08, 2011 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Nov 8, 2011) - Developers are steadily increasing the number of monoclonal antibody products -- known as mAbs -- for which they are initiating clinical studies, extending...
Paradigm Partners has Selected MFG.com as a Strategic Partner With The Goal of Further Educating the Manufacturing Industry about Lucrative Tax Incentives
November 04, 2011 11:04 ET
|
Paradigm Partners
Houston-Atlanta, Nov. 4, 2011 (GLOBE NEWSWIRE) -- MFG.com, the largest online marketplace for the global manufacturing industry, formally announced a strategic partnership with Paradigm Partners of...